A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Clinical trial NCT03670810 · COMPLETED
Trial details
- NCT number
- NCT03670810
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2020-06-12
- Enrollment
- 1633
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.